Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antimicrobial peptides (AMPs) are short, typically cationic peptides found in all classes of life as critical components of the innate immune response. They act as broad-spectrum anti-infectives and exhibit activities against bacteria, fungi, viruses, and parasites, sometimes also showing anti-tumor effects. Their primary mechanisms include disrupting microbial membranes, inhibiting synthesis of macromolecules, and modulating immune responses. They are structurally diverse and classified by sequence, source, 3D structure, and biosynthetic mechanisms. While numerous antimicrobial peptides are clinically or experimentally relevant, "antimicrobial proteins" is a generic term that encompasses many molecules, some of which may be developed as therapeutics, but is not itself a drug target, receptor, or gene product.
Membrane disruption and cell lysis ("carpet," "barrel-stave," "toroidal-pore," "disordered toroidal-pore" models); Inhibition of cell wall synthesis; Inhibition of DNA, RNA, and protein synthesis; Activation of autolysins and other cell death pathways; Immune modulation (chemotaxis, induction of cytokines)
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antimicrobial peptide (AMP) (AMP).